CPBIO Holding Company Limited
CAIHF · Other OTC · USD
1,0677USD
0,00 (0,00 %)Stand 9. Nov., 21:00
Kennzahlen
- Eröffnung
- 0,28
- Vortag
- 1,0677
- Tagesspanne
- 0,0015 – 1,0677
- 52 Wochen
- 0,0015 – 1,07
- Volumen
- 10
- Ø Volumen
- 8
- Börsenwert
- 270,48 Mio. $
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 4,1
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
CPBIO Holding Company Limited is a global entity primarily involved in the production and distribution of chlortetracycline (CTC) and its associated derivatives. The company's business activities span Mainland China, the Asia Pacific region, the Americas, Europe, and other international markets, and are organized into two principal divisions: Biochemical and Industrial. The Biochemical segment concentrates on the formulation and commercialization of CTC premix and CTC hydrochloride products. These substances function as crucial feed additives for livestock, designed to foster growth, ward off or alleviate animal ailments, and enhance feed efficiency, marketed under the "Shihao" and "Citifac" brand names. In contrast, the Industrial segment encompasses the sale, rental, and maintenance services for various Caterpillar heavy equipment, including excavators, power generators, bulldozers, and compactors, alongside their corresponding spare parts. This division also undertakes the manufacturing and supply of carburetors and diverse automotive components for vehicle and motorcycle producers. Established in 1987, the company is headquartered in Central, Hong Kong. Formerly known as Chia Tai Enterprises International Limited, it adopted its current name in July 2026 and operates as a subsidiary of Charoen Pokphand Foods Public Company Limited.
- CEO
- Chawalit Na Muangtoun
- Mitarbeitende
- 900
- Hauptsitz
- Hong Kong, HK
- Sektor
- Healthcare
- Branche
- Drug Manufacturers - Specialty & Generic
- Börsengang
- 22. Aug. 2023
- Website
- cp-bio.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.